US Stock MarketDetailed Quotes

PLRX Pliant Therapeutics

Watchlist
  • 12.660
  • +0.840+7.11%
Close May 1 16:00 ET
  • 12.660
  • 0.0000.00%
Post 16:01 ET
763.64MMarket Cap-4603P/E (TTM)

About Pliant Therapeutics Company

Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-?1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolPLRX
Company NamePliant Therapeutics
Listing DateJun 3, 2020
Issue Price16.00
Founded2015
CEODr. Bernard Coulie, M.B.A.,M.D.,PhD
MarketNASDAQ
Employees158
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address260 Littlefield Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-481-6770
Websitehttp://www.pliantrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Bernard Coulie, M.B.A.,M.D.,PhD
  • Director, President, and Chief Executive Officer
  • 11.17M
  • Hans Hull, J.D.
  • Chief Business Officer
  • 4.36M
  • Lily Cheung
  • Chief Human Resources Officer
  • --
  • Dr. Keith Cummings, M.B.A.,M.D.
  • Chief Financial Officer and Principal Accounting Officer
  • 4.44M
  • Dr. Eric Lefebvre, M.D.
  • Chief Medical Officer
  • 4.69M
  • Smital Shah, M.B.A.
  • Independent Director
  • 277.96K
  • Gayle A. Crowell
  • Independent Director
  • 278.71K
  • Thomas A. McCourt
  • Independent Director
  • 746.57K
  • Dr. Suzanne L. Bruhn, PhD
  • Independent Director
  • 277.21K
  • Dr. Katharine Knobil, M.D.
  • Independent Director
  • 275.21K
  • Dr. Hoyoung Huh,M.D.,PhD
  • Lead Independent Director
  • 296.71K
  • David E.I. Pyott, M.B.A.,M.D.
  • Independent Director
  • 275.46K
  • Darren S. Cline, M.B.A.
  • Independent Director
  • 748.63K
  • Dr. John T. Curnutte, M.D.,PhD
  • Independent Director
  • 271.96K
  • Mike Ouimette, J.D.
  • General Counsel and Corporate Secretary
  • 3.32M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg